Clinical Trial Updates: Early Data on Remdesivir for Severe COVID-19

April 29, 2020

New clinical trial updates on remdesivir as a potential treatment for coronavirus disease 2019 (COVID-19) were announced today.

Sarilumab Trial for Treatment of COVID-19 to Include Only ‘Critical’ Patients

April 27, 2020

Regeneron and Sanofi will amend their ongoing trial of sarilumab (Kevzara) to enroll only “critical” hospitalized patients with COVID-19.

NIH Panel Develops COVID-19 Treatment Guidelines

April 21, 2020

The guidelines provide clinical recommendations to providers treating patients with coronavirus disease 2019 (COVID-19).

Temple University Hospital Begins Clinical Trial of Gimsilumab for Combatting COVID-19

April 16, 2020

In 2 prior clinical studies, gimsilumab demonstrated favorable results in treating the novel coronavirus.

FDA Approves Use of Rutgers University Saliva Test for COVID-19

April 14, 2020

In collaboration with Spectrum Solutions and Accurate Diagnostic Labs, RUCDR Infinite Biologics developed the new collection approach, which utilizes saliva as the primary test biomaterial for COVID-19. 

Children May Not Always Have Fever, Cough with COVID-19 Infection

April 09, 2020

Children with the novel coronavirus disease 2019 (COVID-19) may not develop a fever or cough as often as adults with the virus.

Study Investigates COVID-19 Mortality, Early Indicators of Poor Prognosis

April 08, 2020

As COVID-19 continues to spread, and the death toll rises, experts aim to better understand the clinical features of the disease and factors for increased mortality.

Incyte, Novartis Plan Phase 3 Trial for Ruxolitinib in COVID-19

April 06, 2020

The study will evaluate ruxolitinib (Jakavi) for the treatment of COVID-19-associated cytokine storm.

New Treatment Approach Proposed for Respiratory Distress in COVID-19

March 26, 2020

Tissue plasminogen activator, which is used to treat blood clots, may help severely ill patients with COVID-19 who are in respiratory failure, according to a new paper.

Growing Shortage of Albuterol Inhalers Due to COVID-19, ACAAI Advises

March 23, 2020

Due to the increased need for albuterol inhalers in hospitals for COVID-19, shortages have been occurring in some areas of the country and will likely continue to affect supplies.